Destroying Myelin-damaging Immune Cells May Be New Therapy

Destroying Myelin-damaging Immune Cells May Be New Therapy

298242

Destroying Myelin-damaging Immune Cells May Be New Therapy

Vesicles containing the chemotherapeutic agent doxorubicin can be used to destroy the aberrant, myelin-damaging immune cells that contribute to multiple sclerosis (MS), suppressing the progression of the neurodegenerative disorder, according to recent research findings using a mouse model. If further validated, this technique could provide physicians with a new way to treat MS. “We strongly believe that our therapeutic strategy … will become a new therapy for MS and make a new avenue of hope…

You must be logged in to read/download the full post.